Rigel Pharmaceuticals appoints Alison Hannah as executive vice president and chief medical officer
read at STAT ↗Positive
Rigel Pharmaceuticals announced that it has hired Alison Hannah to serve as executive vice president and chief medical officer.
Hannah joins Rigel after holding the same senior medical leadership role at CytomX Therapeutics, where she oversaw clinical development and medical affairs.
The appointment adds a seasoned executive to Rigel’s leadership team as the company continues to advance its pipeline and strategic initiatives.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗459 words · retrieved Jul 24
comments(0)
5-min edit window · permanent after that